MEMs

RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs

SAN CARLOS, Calif.–(BUSINESS WIRE)–RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered…

Read More »